As of December 14, the Southeast Asian country recorded 1,499 casespositive to COVID-19 nationwide. Among them, there were 359 new cases reportedthe same day, and five fatalities recorded in previous week.
EG.5, a sub-variant of Omicron, is believed to be the primarycause of the recent surge in COVID-19 cases in Indonesia and other countries inthe region. EG.5 has a lower fatality rate compared to other sub-variants.
The ministry’s spokesperson Siti Nadia Tarmizi said the ministryis in negotiations to provide the fifth COVID-19 vaccine dose, or a thirdbooster next year, especially for those at high risk of virus exposure.
Also as of December 14, about 203 million people in Indonesia, or86% of the target population, received the first vaccine dose. As many as 175million people obtained the second booster dose, while 69 million others gotthe first booster shot./.